These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8969316)

  • 1. Canada's new guidelines for the economic evaluation of pharmaceuticals.
    Menon D; Schubert F; Torrance GW
    Med Care; 1996 Dec; 34(12 Suppl):DS77-86. PubMed ID: 8969316
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of economic evaluation guidelines: 2 years' experience in Canada.
    Baladi JF; Menon D; Otten N
    Health Econ; 1998 May; 7(3):221-7. PubMed ID: 9639335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmaco-economic evaluations of new drugs: potential key to a more efficient allocation of the health care budget].
    Delwel GO; Sprenger MJ
    Ned Tijdschr Geneeskd; 2002 Jun; 146(23):1068-71. PubMed ID: 12085554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managed care guidelines for the economic evaluation of pharmaceuticals.
    Langley PC; Martin RE
    Am J Manag Care; 1997 Jul; 3(7):1013-21. PubMed ID: 10173366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing prescription medications for priority regulatory review.
    Rawson NS
    Regul Toxicol Pharmacol; 2005 Jun; 42(1):70-6. PubMed ID: 15896445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Report from the Canadian Coordinating Office for Health Technology Assessment (CCOHTA). Guidelines for economic evaluation of pharmaceuticals: Canada.
    Int J Technol Assess Health Care; 1995; 11(4):796-7. PubMed ID: 8567213
    [No Abstract]   [Full Text] [Related]  

  • 7. [Guidelines for economic evaluation of drugs. Something for Sweden?].
    Persson U
    Lakartidningen; 1997 Jun; 94(24):2289-92. PubMed ID: 9213707
    [No Abstract]   [Full Text] [Related]  

  • 8. Canada's unemployment-immigration linkage: demographic, economic, and political influences.
    Foot DK
    Can J Sociol; 1994; 19(4):513-23. PubMed ID: 12291276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacoeconomic component of a clinical trial conducted in Latin America. Conceptual and empirical considerations.
    Reinharz D; Saldaña VR; Follador W; Asche C
    Int J Technol Assess Health Care; 2001; 17(4):571-8. PubMed ID: 11758300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation methodology of viral vaccines].
    Aymard M
    Therapie; 1996; 51(4):439-43. PubMed ID: 8953827
    [No Abstract]   [Full Text] [Related]  

  • 11. Mixed reviews for Canada's new food guide.
    Andresen M
    CMAJ; 2007 Mar; 176(6):752-3. PubMed ID: 17353520
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluating the role of bias in pharmacoeconomic studies.
    Joish VN
    Manag Care Interface; 2001 Aug; 14(8):57-60. PubMed ID: 11517839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The November 1995 revised Australian guidelines for the economic evaluation of pharmaceuticals.
    Langley PC
    Pharmacoeconomics; 1996 Apr; 9(4):341-52. PubMed ID: 10160108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Agreement between guidelines for pharmaco-economic research and never-before-published health-economics evaluations].
    Postma MJ; Kwik JJ; Rutten WJ; de Jong-van den Berg LT; Brouwers JR
    Ned Tijdschr Geneeskd; 2002 Jun; 146(23):1082-7. PubMed ID: 12085558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International Conference on Harmonisation; evaluation of stability data; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Jun; 69(110):32010-1. PubMed ID: 15185712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicine reimbursement recommendations in Canada, Australia, and Scotland.
    Lexchin J; Mintzes B
    Am J Manag Care; 2008 Sep; 14(9):581-8. PubMed ID: 18778173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standardization of the economic evaluation of health technologies. European developments.
    Rovira J
    Med Care; 1996 Dec; 34(12 Suppl):DS182-8. PubMed ID: 8969325
    [No Abstract]   [Full Text] [Related]  

  • 18. Which cancer clinical trials should be considered for economic evaluation? Selection criteria from the National Cancer Institute of Canada's Working Group on Economic Analysis.
    Evans WK; Coyle D; Gafni A; Walker H;
    Chronic Dis Can; 2003; 24(4):102-7. PubMed ID: 14733759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining types of economic evaluation.
    Ngorsuraches S
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S21-7. PubMed ID: 19255985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines for measuring the costs and consequences of adopting new pharmaceutical products: are they on track?
    Pausjenssen AM; Detsky AS
    Med Decis Making; 1998; 18(2 Suppl):S19-22. PubMed ID: 9566463
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.